Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011467
Filing Date
2024-08-08
Accepted
2024-08-08 07:30:38
Documents
96
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20240630x10q.htm   iXBRL 10-Q 1987801
2 EX-31.1 ipsc-20240630xex31d1.htm EX-31.1 14640
3 EX-31.2 ipsc-20240630xex31d2.htm EX-31.2 14479
4 EX-32.1 ipsc-20240630xex32d1.htm EX-32.1 6974
5 EX-32.2 ipsc-20240630xex32d2.htm EX-32.2 6971
6 GRAPHIC ipsc-20240630xex31d1001.jpg GRAPHIC 939
7 GRAPHIC ipsc-20240630xex31d2001.jpg GRAPHIC 939
  Complete submission text file 0001558370-24-011467.txt   9529266

Data Files

Seq Description Document Type Size
8 EX-101.SCH ipsc-20240630.xsd EX-101.SCH 64351
9 EX-101.CAL ipsc-20240630_cal.xml EX-101.CAL 74334
10 EX-101.DEF ipsc-20240630_def.xml EX-101.DEF 258197
11 EX-101.LAB ipsc-20240630_lab.xml EX-101.LAB 591551
12 EX-101.PRE ipsc-20240630_pre.xml EX-101.PRE 461624
99 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20240630x10q_htm.xml XML 1737040
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 241186066
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)